Development and in vitro evaluation of fast-dissolving oral films of ondansetron hydrochloride

Ondansetron hydrochloride, a selective 5-HT3 receptor blocker, is an effective antiemetic drug with oral bioavailability of %60 and half-life of 4-5 h. The present study was carried out to prepare fast dissolving films of ondansetron hydrochloride to increase patient compliance and improve efficacy...

Full description

Saved in:
Bibliographic Details
Main Authors: Shohreh Alipour (Author), Sahar Akbari (Author), Fatemeh Ahmadi (Author)
Format: Book
Published: Shiraz University of Medical Sciences, 2015-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_905e9f79b45f474cbf63692f08fbb0bd
042 |a dc 
100 1 0 |a Shohreh Alipour  |e author 
700 1 0 |a Sahar Akbari  |e author 
700 1 0 |a Fatemeh Ahmadi  |e author 
245 0 0 |a Development and in vitro evaluation of fast-dissolving oral films of ondansetron hydrochloride 
260 |b Shiraz University of Medical Sciences,   |c 2015-03-01T00:00:00Z. 
500 |a 2423-5652 
520 |a Ondansetron hydrochloride, a selective 5-HT3 receptor blocker, is an effective antiemetic drug with oral bioavailability of %60 and half-life of 4-5 h. The present study was carried out to prepare fast dissolving films of ondansetron hydrochloride to increase patient compliance and improve efficacy of drug. Films were prepared by solvent casting method, using poly vinyl alcohol, poly vinyl pyrrolidone and konjacglucomannan as film formers and PEG400 as plasticizer. Natural and synthetic sweeteners were used for masking bitterness of drug. Satisfactory results were obtained from evaluation of physical characteristics of fast dissolving films of ondansetron hydrochloride including:  thickness: 37-39mm, surface pH: 6.77, folding endurance: up to 300 time and tensile strength: 35.75-50.93g/cm². Films were also subjected to an in vitro dissolution and release studies. In vitro drug release studies indicated 93-95% release in 5 min. Fast dissolving films of ondansetron could be a potential alternative for the currently marketed oral formulation, parenteral form and suppository with better patient compliance and higher bioavailability for the rapid control of emesis. 
546 |a EN 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Trends in Pharmaceutical Sciences, Vol 1, Iss 1, Pp 25-30 (2015) 
787 0 |n http://tips.sums.ac.ir/article_42149_43a2c816e2b68b51bd7d427dbb311b8e.pdf 
787 0 |n https://doaj.org/toc/2423-5652 
856 4 1 |u https://doaj.org/article/905e9f79b45f474cbf63692f08fbb0bd  |z Connect to this object online.